- Home
- DUO vs GLMD Comparison
DUO vs GLMD Comparison
Compare DUO & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DUO
- GLMD
- Stock Information
- Founded
- DUO 2011
- GLMD 2000
- Country
- DUO China
- GLMD Israel
- Employees
- DUO N/A
- GLMD N/A
- Industry
- DUO Real Estate
- GLMD Biotechnology: Pharmaceutical Preparations
- Sector
- DUO Finance
- GLMD Health Care
- Exchange
- DUO Nasdaq
- GLMD Nasdaq
- Market Cap
- DUO 6.1M
- GLMD 6.6M
- IPO Year
- DUO 2019
- GLMD 2014
- Fundamental
- Price
- DUO $1.82
- GLMD $1.11
- Analyst Decision
- DUO
- GLMD Hold
- Analyst Count
- DUO 0
- GLMD 1
- Target Price
- DUO N/A
- GLMD N/A
- AVG Volume (30 Days)
- DUO 185.6K
- GLMD 6.1M
- Earning Date
- DUO 11-19-2025
- GLMD 11-14-2025
- Dividend Yield
- DUO N/A
- GLMD N/A
- EPS Growth
- DUO N/A
- GLMD N/A
- EPS
- DUO N/A
- GLMD N/A
- Revenue
- DUO $56,189,313.00
- GLMD N/A
- Revenue This Year
- DUO N/A
- GLMD N/A
- Revenue Next Year
- DUO N/A
- GLMD N/A
- P/E Ratio
- DUO N/A
- GLMD N/A
- Revenue Growth
- DUO 48.30
- GLMD N/A
- 52 Week Low
- DUO $1.24
- GLMD $1.01
- 52 Week High
- DUO $24.64
- GLMD $3.61
- Technical
- Relative Strength Index (RSI)
- DUO 35.53
- GLMD 34.34
- Support Level
- DUO $1.76
- GLMD $1.01
- Resistance Level
- DUO $2.20
- GLMD $1.54
- Average True Range (ATR)
- DUO 0.16
- GLMD 0.12
- MACD
- DUO 0.02
- GLMD -0.02
- Stochastic Oscillator
- DUO 6.38
- GLMD 16.98
About DUO Fangdd Network Group Ltd.
Fangdd Network Group Ltd is an investment holding company. It is engaged in the provision of real estate information services through its online platform which also offers integrated marketing services for individual customers, real estate developers, and agents in China. Its SaaS-based solutions help real estate agents to connect with essential business resources, including customers, property listings, capital, and transaction data. The company generates the majority of its revenue from Base commission from transactions in China.
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.